Trial intelligence / Profile preview

Intracoronary vs Intravenous Abciximab in Non-ST Elevation Myocardial Infarction

NCT01080638Phase 4Terminated

Sponsor
Seoul National University Hospital
Start
Aug 2009
Primary completion
Dec 2012
Modality
Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of abciximab in myocardial infarction (MI), sponsored by Seoul National University Hospital. Started Aug 2009; status: terminated.

02

Drugs

abciximab
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT01080638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01080638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call